These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7730233)

  • 1. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
    Drugeon HB; Caillon J; Juvin ME
    J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
    Grohs P; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 2003 Jan; 47(1):418-20. PubMed ID: 12499229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
    Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
    Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.
    Røder BL; Gutschik E
    J Antimicrob Chemother; 1989 Mar; 23(3):347-52. PubMed ID: 2732119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M
    J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains.
    Aktas G; Derbentli S
    J Glob Antimicrob Resist; 2017 Sep; 10():223-227. PubMed ID: 28735049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT
    J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
    Simon VC; Simon M
    Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus resistance to antibiotics and spread of phage types.
    Kareiviene V; Pavilonis A; Sinkute G; Liegiūte S; Gailiene G
    Medicina (Kaunas); 2006; 42(4):332-9. PubMed ID: 16687905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.
    O'Neill AJ; Cove JH; Chopra I
    J Antimicrob Chemother; 2001 May; 47(5):647-50. PubMed ID: 11328777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
    Norazah A; Lim VK; Rohani MY; Kamel AG
    Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
    Guenthner SH; Wenzel RP
    Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR).
    Gottlieb T; Mitchell D
    J Antimicrob Chemother; 1998 Jul; 42(1):67-73. PubMed ID: 9700530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
    J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Graninger W; Leitha T; Havel M; Georgopoulos A
    Infection; 1984; 12(4):293-5. PubMed ID: 6092279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro synergy testing of triple antibiotic combinations against Staphylococcus epidermidis isolates from patients with endocarditis.
    Yu VL; Zuravleff JJ; Bornholm J; Archer G
    J Antimicrob Chemother; 1984 Oct; 14(4):359-66. PubMed ID: 6501129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.
    Haag R
    Infection; 1986; 14(1):38-43. PubMed ID: 3957435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
    Voss A; Machka K; Lenz W; Milatovic D
    Dtsch Med Wochenschr; 1992 Dec; 117(50):1907-12. PubMed ID: 1459021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM; Ishag AH; Durgham SM
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.